Ligand validation:2RJ7

GDU: GALACTOSE-URIDINE-5'-DIPHOSPHATE

GDU is a Ligand Of Interest in 2RJ7 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2RJ7_GDU_A_475	62%	9%	0.127	0.919	2.06	2.43	6	13	0	0	100%	1
6GX0_GDU_A_402	97%	47%	0.067	0.98	0.81	1.22	1	6	0	0	100%	0.6
5M7D_GDU_A_402	97%	44%	0.071	0.983	0.91	1.26	1	6	0	0	100%	1
5C1H_GDU_A_402	66%	42%	0.126	0.93	0.94	1.32	2	7	1	0	100%	1
5C1L_GDU_A_403	65%	35%	0.115	0.917	0.91	1.63	1	9	0	0	100%	1
5C1G_GDU_A_403	58%	35%	0.131	0.908	0.96	1.57	3	8	0	0	100%	0.9083
4HO9_GDU_B_300	99%	24%	0.05	0.983	1.38	1.71	4	9	0	0	100%	1
7YS9_GDU_A_404	91%	78%	0.087	0.974	0.39	0.51	-	1	1	0	100%	0.4
4LW3_GDU_A_402	89%	11%	0.104	0.983	2.67	1.52	15	10	0	0	100%	1
2FYC_GDU_D_528	86%	27%	0.102	0.971	1.41	1.53	4	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.